207 related articles for article (PubMed ID: 27646031)
1. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.
Tamura RE; da Silva Soares RB; Costanzi-Strauss E; Strauss BE
Cancer Biol Ther; 2016 Dec; 17(12):1221-1230. PubMed ID: 27646031
[TBL] [Abstract][Full Text] [Related]
2. Induction of Oxidants Distinguishes Susceptibility of Prostate Carcinoma Cell Lines to p53 Gene Transfer Mediated by an Improved Adenoviral Vector.
Tamura RE; Hunger A; Fernandes DC; Laurindo FR; Costanzi-Strauss E; Strauss BE
Hum Gene Ther; 2017 Aug; 28(8):639-653. PubMed ID: 28181816
[TBL] [Abstract][Full Text] [Related]
3. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated p53 treatment enhances photodynamic antitumor response.
Lim DS; Bae SM; Kwak SY; Park EK; Kim JK; Han SJ; Oh CH; Lee CH; Lee WY; Ahn WS
Hum Gene Ther; 2006 Mar; 17(3):347-52. PubMed ID: 16544983
[TBL] [Abstract][Full Text] [Related]
6. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
Eastham JA; Grafton W; Martin CM; Williams BJ
J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
8. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
9. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth.
Tamura RE; Lana MG; Costanzi-Strauss E; Strauss BE
Gene Ther; 2020 Feb; 27(1-2):15-26. PubMed ID: 30926960
[TBL] [Abstract][Full Text] [Related]
10. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
12. Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo.
Xande JG; Dias AP; Tamura RE; Cruz MC; Brito B; Ferreira RA; Strauss BE; Costanzi-Strauss E
Gene Ther; 2020 Feb; 27(1-2):51-61. PubMed ID: 31439890
[TBL] [Abstract][Full Text] [Related]
13. Improving adenoviral vectors and strategies for prostate cancer gene therapy.
Tamura RE; de Luna IV; Lana MG; Strauss BE
Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e476s. PubMed ID: 30133562
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.
Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C
Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275
[TBL] [Abstract][Full Text] [Related]
15. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
[TBL] [Abstract][Full Text] [Related]
16. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo.
Gu J; Wang B; Liu Y; Zhong L; Tang Y; Guo H; Jiang T; Wang L; Li Y; Cai L
Eur J Cancer; 2014 Apr; 50(6):1184-94. PubMed ID: 24447832
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells.
Schumacher G; Bruckheimer EM; Beham AW; Honda T; Brisbay S; Roth JA; Logothetis C; McDonnell TJ
Int J Cancer; 2001 Jan; 91(2):159-66. PubMed ID: 11146439
[TBL] [Abstract][Full Text] [Related]
20. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]